Dr. Haseltine is the CEO of Demetrix and was previously professor and founder of two departments at Harvard Medical School, one on HIV/AIDS and one on cancer biology. Dr. Haseltine led Human Genome Sciences, one of the first companies to apply genetics to treat disease, and founded several other biotechnology companies. Dr. Haseltine leads the Haseltine Foundation for Science and the Arts, and ACCESS Health International, both non-profits in health and the humanities.
Demetrix is named after Demeter, the greek goddess of the harvest.
Demetrix raises a $50,000,000 series A round from Horizons Ventures and Tuatara Capital.
Documentaries, videos and podcasts
- Synthetic biologyInterdisciplinary branch of biology and engineering, applying multiple disciplines to build artificial biological systems for research, engineering, and medical applications.
- Harvard Medical SchoolMedical school in boston, ma
- Human Genome SciencesA biopharmaceutical and healthcare company